Humanized Mice Model Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Model Type (Genetic Humanized Mice Model, Cell-Based Humanized Mice Model); Application (Toxicology, Oncology, Infectious Diseases, GvHD, Regenerative Medicine, Neurobiology, Others); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and geography
In order to increase the similarity to human metabolism, technological advances in humanised mice models include the introduction of human genetic material into mice and research into more numbers of human-specific infectious agents, representing an opportunity for existing market players. It is anticipated that the development of next-gen humanised mouse models will provide exciting opportunities to develop robust small animal models to study the pathogenesis of human-specific transferrable agents and to assess the effectiveness and toxicity of novel experimental vaccines and therapeutic agents.
Factors driving the growth of the humanized mice model market are the Increasing demand for more effective screening of new drug candidates discovered by the healthcare industry to treat a number of chronic diseases such as cardiovascular diseases, diabetes, and cancers, coupled with an emergence of new players due to the growing demand for better mouse models that are capable of overcoming the limitations of xenograft models. However, the high cost of vegetarian humanized mice model is expected to hamper the growth of the market. Moreover, rising demand for personalized medicine is anticipated to boost the market growth.
The "Humanized Mice Model Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of humanized mice model market with detailed market segmentation by model type, application and end user. The humanized mice model market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in humanized mice model market and offers key trends and opportunities in the market.
The humanized mice model market is segmented on the basis of model type, application and end user. Based on model type, the market is segmented as genetic humanized mice model and cell-based humanized mice model. Cell-based humanized mice model is sub segmented as CD-34 and PBMC. On the basis of application, the market is categorized as toxicology, oncology, infectious diseases, GvHD, regenerative medicine, neurobiology, and others. On the basis of end user, the market is categorized as pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the humanized mice model market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The humanized mice model market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting humanized mice model market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the humanized mice model market in these regions.
Get more information on this report :
The report covers key developments in the humanized mice model market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from humanized mice model market are anticipated to have lucrative growth opportunities in the future with the rising demand for humanized mice model in the global market. Below mentioned is the list of few companies engaged in the humanized mice model market.
The report also includes the profiles of key players in humanized mice model market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
THE JACKSON LABORATORY
Taconic Biosciences, Inc.
Ingenious Targeting Laboratory Inc.
orizon Discovery Group plc.
Charles River Laboratories, Inc.
Crown Bioscience Inc.
Trans Genic Inc., Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Genoway S.A.
2. Yecuris Corporation
3. THE JACKSON LABORATORY
4. Taconic Biosciences, Inc.
5. Ingenious Targeting Laboratory Inc.
6. orizon Discovery Group plc.
7. Charles River Laboratories, Inc.
8. Crown Bioscience Inc.
9. HuMurine Technologies
10. Trans Genic Inc., Ltd.